Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.
1. A method of treating or decreasing incidence of growth delay associated with enteral feeding tolerance in an infant or young child in need thereof, the method comprising administering a composition to the infant or young child, the composition comprising lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), 3′ sialyllactose (3-SL), 6′ sialyllactose (6-SL), and 2′-fucosyllactose (2-FL) as the only human milk oligosaccharides in the composition, wherein the composition comprises the LNT and the LNnT in a ratio LNT:LNnT between 5:1 and 1:2.
2. The method according to claim 1 , wherein each of the lacto-N-tetraose (LNT), the lacto-N-neotetraose (LNnT), the 3′ sialyllactose (3-SL), the 6′ sialyllactose (6-SL), and the 2′-fucosyllactose (2-FL) are present in an amount from 0.1 to 20 g/L of the composition.
3. The method according to claim 1 , wherein the composition further comprises at least one probiotic in an amount of from 10 3 to 10 12 cfu/g of the composition (dry weight).
4. The method according to claim 1 , wherein the composition is in a form selected from the group consisting of an infant formula, a starter infant formula, a follow-on infant formula, a baby food, an infant cereal composition, a growing-up milk, a fortifier and a supplement.
5. The method according to claim 1 , wherein the composition is administered to the infant or young child before and/or during the weaning period.
6. The method according to claim 1 , wherein the infant or young child is selected from the group consisting of preterm infants, small for gestational age infants, and infants born by C-section.